Articles tagged "Kidney transplantation"

2019 American Transplant Congress
Hypertrophy Prediction Model for Contralateral Kidney after Living Donation
K. Okumura¹, K. Tanaka², Y. Hidaka², M. Toyoda³, S. Uekihara³, A. Inadome⁴, H. Yokomizo², S. Yamanaga²
¹Department of Surgery, University of Pittsburgh, Pittsburgh, PA, ²Department of Surgery, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan, ³Department of Nephrology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan, ⁴Department of Urology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan
*Purpose: Compensation of contralateral kidney function is well established and many factors have been proposed as risk factors. There is no prediction model to estimate…
2019 American Transplant Congress
Mitigating Racial and Gender Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation’s Longest Single-Center Kidney Chain
M. N. Mustian, V. Kumar, K. Stegner, D. Mompoint-Williams, M. Hanaway, M. H. Deierhoi, C. Young, B. Orandi, D. Anderson, P. A. MacLennan, R. D. Reed, B. A. Shelton, D. Eckhoff, J. E. Locke
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Disparities in access to living donor kidney transplantation (LDKT) exist among minorities and women and may be partially explained by antigen sensitization secondary to…
2019 American Transplant Congress
The Inverted Renal CD4/CD8 Ratio Associated with the Development of Transplant Glomerulopathy and Arteriosclerosis
B. H. Ozdemir¹, F. N. Ozdemir², A. Ok Atılgan¹, E. Akcay¹, M. Haberal³
¹Pathology, Baskent University, Ankara, Turkey, ²Nephrology, Baskent University, Ankara, Turkey, ³Transplantation, Baskent University, Ankara, Turkey
*Purpose: Inversion of the CD4/CD8 ratio (
2019 American Transplant Congress
The Interaction between Post-Transplant Anemia and Allograft Function in Kidney Transplantation
Y. Kakuta¹, M. Okumi¹, T. Kanzawa¹, K. Unagami², H. Ishida², K. Tanabe¹
¹Urology, Tokyo Women's Medical University, Tokyo, Japan, ²Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan
*Purpose: Post-transplant anemia (PTA) is one of the common complications, which was observed in about 30% to 40% of kidney transplant recipients. The interaction effect…
2019 American Transplant Congress
Engaging Friends and Family in the Care of the Kidney Transplant Candidate: Identifying Needs and Barriers
A. Hart¹, M. Bruin², M. Partin³, A. Matas⁴, A. Israni¹
¹Medicine, Hennepin Healthcare, University of Minnesota, Minneapolis, MN, ²Design, University of Minnesota, Minneapolis, MN, ³Medicine, Minneapolis VA, University of Minnesota, Minneapolis, MN, ⁴Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Research suggests that including social support networks in the kidney transplant education process improves evaluation completions and increases living donor rates, but the optimal…
2019 American Transplant Congress
Prediction of Renal Allograft Chronic Rejection Using a Model Based on Contrast Enhanced Ultrasonography
C. Yang¹, T. Zhu¹, W. He²
¹Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China, ²Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China
*Purpose: To evaluated the application of contrast enhanced ultrasonography (CEUS) in diagnosis of renal allograft chronic rejection (CR).*Methods: Sixty-six renal transplantation recipients were enrolled in…
2019 American Transplant Congress
Continuous 24-Hour vs. Daily Antithymocyte Globulin (ATG) Infusions for Treatment of Renal Allograft Rejection: Preliminary Results of a Prospective Trial
S. J. Patel, S. Kuten, R. Knight, J. Nolte-Fong, D. Nguyen, E. Graviss, A. Gaber
Methodist Hospital, Houston, TX
*Purpose: When used for acute rejection (AR), ATG is generally administered in the inpatient setting, given the need for intravenous (IV) access, risk of infusion-related…
2019 American Transplant Congress
Effects of Statin Use on Cardiovascular Outcome in Patients with Renal Transplantation
J. Kim¹, K. Park¹, S. Park¹, M. Yu², Y. Kim¹, K. Kim¹, M. Park³, H. Lee¹
¹Seoul National University Hospital, Seoul, Korea, Republic of, ²Hanyang University Guri Hospital, Gyeonggi-do, Korea, Republic of, ³Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: Cardiovascular disease is the main cause of death among patients with end-stage renal disease (ESRD). Statin, HMG-CoA reductase inhibitor, is well known to significantly…
2019 American Transplant Congress
Postoperative Atrial Fibrillation in Kidney Transplant Recipients: A Retrospective Study Evaluating Risk of Anticoagulation
P. Serrano Rodriguez¹, A. Vijayakumar², P. D. Strassle³, K. Szempruch¹, C. S. Desai¹, A. Vijay¹, A. H. Toledo¹, D. A. Gerber¹
¹Abdominal Transplant SUrgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, ²School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, ³General Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC
*Purpose: Patients with atrial fibrillation (AF) have a higher risk of mortality and adverse cardiovascular events. Pre-operative AF has around 5-9% prevalence and roughly 5%…
2019 American Transplant Congress
Prolonged Fluoroquinolone Prophylaxis to Prevent BK Viremia in Kidney Transplant Recipients
S. A. Muhsin¹, S. J. Ripley², M. L. Jacobs³, K. Safa¹, D. M. Wojciechowski¹
¹Nephrology Division, MGH, Boston, MA, ²Cancer Center, MGH, Boston, MA, ³Wake Forest University School of Medicine, Winston-Salem, NC
*Purpose: Prophylaxis for kidney transplant recipients has successfully lowered early incidence of infections such as CMV. However, there are no approved agents for the prevention…